Finally, the CCK-8 and flow cytometry assay was utilized to investigate Wee1 and imatinib’s synergistic effect, and a CML mouse model was constructed to study Wee1’s role in carcinogenesis in vivo. The gene discussed is WEE1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.